Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumors
替凡替尼联合贝伐单抗治疗晚期实体瘤成人患者的安全性、药代动力学和药效学的 1 期研究
期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.7
doi:10.1007/s00280-021-04317-y
William F Maguire, John C Schmitz, Jonas Scemama, Ken Czambel, Yan Lin, Anthony G Green, Shaoyu Wu, Huang Lin, Shannon Puhalla, John Rhee, Ronald Stoller, Hussein Tawbi, James J Lee, John J Wright, Jan H Beumer, Edward Chu, Leonard J Appleman; ETCTN-9153 Study Team
